Sanara MedTech dropped its Tissue Health Plus (THP) platform as part of an overall corporate realignment that focuses ...

In 2022, the WHO hailed Novartis’ GanLum as the most promising non-artemisinin-based combination. The Swiss drugmaker ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...

Grail saw a sharp rise in third-quarter sales as it outlined a firmer FDA submission date for its Galleri cancer blood test. | Grail saw a sharp rise in third-quarter sales as it outlined a firmer FDA ...

After forming from a merger hashed out over plates of tacos about a year ago, nChroma Bio is laying off staff and ...

AbbVie is ending an eleven-year agreement with Alphabet’s Calico Labs, according to an internal email obtained by Stat News.

Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute, tapping into SCRI ...

Korro Bio delivered a double whammy of bad news, reporting lackluster data on its lead candidate and a pause to its partnership with Novo Nordisk. The biotech, which suffered a 79% stock drop in the ...

Who would have predicted that one of the hottest trends for beleaguered biotechs in 2025 would be to rebrand as a crypto company? | Who would have predicted that one of the hottest trends for ...

Alkermes has reported another phase 2 win for its narcolepsy drug candidate, succeeding where Takeda failed to maintain its ...

Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of ...

A quarter of Metagenomi’s employees, including the company’s CEO, are set to lose their jobs after the gene editing biotech ...